Abiopharma

News list

Goodwin William Carroll Murphy 🟡 adjusted position in 0 shares (1 derivative) of Oklo Inc. (OKLO) Transaction Date: Aug 12, 2026 | Filing ID: 000009

Full text

News bot Aug. 14, 2026, 8:15 p.m.
🔍 Goodwin William Carroll Murphy (Executive)

Company: Oklo Inc. (OKLO)

Report Date: 2026-08-12
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 20,685
- Total shares sold: 20,685
Detailed Transactions and Holdings:
- Acquired 20,685 shares of Class A Common Stock (Direct)
  Date: 2026-08-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 56,860.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 20,685 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 125,207.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2: On August 12, 2024, the Reporting Person was granted 248,227 RSUs, vesting as to 20% of the underlying shares on August 12, 2025 and continuing to vest thereafter in 24 substantially equal monthly installments. On August 12, 2026, 20,685 RSUs vested.